A. D. Perera

Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes.

L. Heinemann, D. A. Shapiro, T. Heise, 2002, Diabetes care.

Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

S. Mudaliar, Dennis D. Kim, D. A. Shapiro, 2003, Diabetes care.

Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.

L. Heinemann, D. A. Shapiro, T. Heise, 2004, Diabetes technology & therapeutics.